NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in NextCure, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −8 vs. Q4 2024
- Shares held
- 15.4M
- −669.8K (−4.2%) vs. Q4 2024
- Total value
- $7.38M
- −$5.75M (−43.8%) vs. Q4 2024
- New holders
- 0
- 10 more added
- Sold out
- 8
- 9 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NXTC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 30 | $2.78M |
| Q1 2026 | 26 | $23.0M |
| Q4 2025 | 24 | $26.9M |
| Q3 2025 | 17 | $5.03M |
| Q2 2025 | 30 | $5.65M |
| Q1 2025 | 38 | $7.38M |
| Q4 2024 | 46 | $13.1M |
| Q3 2024 | 44 | $21.7M |
| Q2 2024 | 49 | $25.5M |
| Q1 2024 | 47 | $36.0M |
| Q4 2023 | 43 | $15.3M |
| Q3 2023 | 41 | $16.6M |
| Q2 2023 | 43 | $24.0M |
| Q1 2023 | 44 | $19.6M |
| Q4 2022 | 45 | $18.9M |
| Q3 2022 | 52 | $41.8M |
| Q2 2022 | 51 | $67.9M |
| Q1 2022 | 59 | $64.3M |
| Q4 2021 | 71 | $86.2M |
| Q3 2021 | 71 | $99.5M |
| Q2 2021 | 78 | $124.2M |
| Q1 2021 | 92 | $179.8M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding NextCure, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sofinnova Investments, Inc. | 2,671,856 | $1.28M | 0.10% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 2,302,598 | $1.11M | 0.17% | 00.0% | Unchanged |
| Pfizer Inc | 1,891,763 | $908.6K | 0.18% | +433,213+29.7% | Added |
| Citigroup Inc | 1,419,370 | $681.7K | 0.00% | +30,330+2.2% | Added |
| OrbiMed Advisors LLC | 1,141,200 | $548.1K | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 987,324 | $473.9K | 0.00% | 00.0% | Unchanged |
| Cable Car Capital LLC | 670,101 | $321.9K | 0.37% | +54,223+8.8% | Added |
| BlackRock, Inc. | 556,686 | $267.4K | 0.00% | −170,893−23.5% | Reduced |
| Acadian Asset Management LLC | 488,440 | $233.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 479,962 | $230.5K | 0.00% | −39,338−7.6% | Reduced |
| Tang Capital Management LLC | 404,144 | $194.1K | 0.01% | −295,856−42.3% | Reduced |
| Federated Hermes, Inc. | 315,180 | $151.3K | 0.00% | 00.0% | Unchanged |
| BML Capital Management, LLC | 273,536 | $131.4K | 0.11% | 00.0% | Unchanged |
| Peapod Lane Capital LLC | 265,442 | $127.5K | 0.14% | −138,256−34.2% | Reduced |
| Cardiff Park Advisors, LLC | 262,000 | $125.8K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 236,185 | $113.5K | 0.00% | +2,271+1.0% | Added |
| Macquarie Group Ltd | 150,000 | $72.0K | 0.00% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 130,000 | $62.4K | 0.02% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 120,012 | $57.6K | 0.01% | 00.0% | Unchanged |
| Armistice Capital, LLC | 104,000 | $50.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 90,643 | $43.5K | 0.00% | +11,965+15.2% | Added |
| Barclays PLC | 67,518 | $32.4K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 65,392 | $31.4K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 51,700 | $24.8K | 0.00% | −15,900−23.5% | Reduced |
| Northern Trust Corp | 47,493 | $22.8K | 0.00% | 00.0% | Unchanged |
| Ieq Capital, LLC | 37,342 | $17.9K | 0.00% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 25,000 | $12.0K | 0.01% | 00.0% | Unchanged |
| Engineers Gate Manager LP | 20,198 | $9.70K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 18,935 | $9.09K | 0.00% | −2,865−13.1% | Reduced |
| XTX Topco Ltd | 18,028 | $8.66K | 0.00% | +4,451+32.8% | Added |
| HSBC Holdings PLC | 17,257 | $8.45K | 0.00% | −106−0.6% | Reduced |
| Millennium Management LLC | 12,272 | $5.89K | 0.00% | −30,245−71.1% | Reduced |
| Dimensional Fund Advisors LP | 12,175 | $5.85K | 0.00% | −73,678−85.8% | Reduced |
| UBS Group AG | 8,537 | $4.10K | 0.00% | +4,335+103.2% | Added |
| Tower Research Capital LLC (TRC) | 1,869 | $898 | 0.00% | +1,211+184.0% | Added |
| JPMorgan Chase & Co | 807 | $387 | 0.00% | +2+0.2% | Added |
| BNP Paribas Arbitrage, SA | 385 | $185 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 262 | $126 | 0.00% | +10+4.0% | Added |
| Long Focus Capital Management, LLC | 0 | $0 | 0.00% | −185,936−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −107,672−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −58,259−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −48,186−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −22,951−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −20,500−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1,191−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −1−100.0% | Sold out |